SHSE:688266 (China)
Â
Class A
Â¥
56.00
(-1.39%)
Jun 21
New Key Statistics Module, Z-Score and F-Score
SHSE:688266 Key Ratios
Market Cap ¥ M | 14,823.66 |
Enterprise Value ¥ M | 13,407.59 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 9.30 |
Price/Sales | 37.94 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) ¥ M | 386.00 |
EPS (TTM) ¥ | -1.00 |
Beneish M-Score | -2.7 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -51.71 |
EV-to-EBITDA | -51.71 |
PEG | -- |
Shares Outstanding M | 264.71 |
Net Margin (%) | -67.48 |
Operating Margin % | -82.38 |
Pre-tax Margin (%) | -73.43 |
Quick Ratio | 2.15 |
Current Ratio | 2.25 |
ROA % (ttm) | -9.74 |
ROE % (ttm) | -17.42 |
ROIC % (ttm) | -26.86 |
Dividend Yield % | -- |
Altman Z-Score | 5.44 |
SHSE:688266 Number of Guru Trades
SHSE:688266 Volume of Guru Trades
Gurus Latest Trades with SHSE:688266
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SHSE:688266 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Suzhou Zelgen Biopharmaceuticals Co Ltd Insider Transactions
No Available Data